Pliant Therapeutics Inc expected to post a loss of 71 cents a share - Earnings Preview

Pliant Therapeutics

04/08/2023 15:01

* Pliant Therapeutics Inc  PLRX.OQ   PLRX.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 7
(estimated). 
    * The South San Francisco California-based  company is
expected to
report  a 82.3% decrease in revenue to $881.82 thousand from
$4.99 million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Pliant Therapeutics
Inc
is for a loss of 71 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 14 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pliant
Therapeutics Inc is $48​, above​ its last closing price
of $19.50. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.65       -0.67      -0.67     Met     -0.2
 Dec. 31 2023  -0.70       -0.70      -0.72     Missed  -2.8
 Sep. 30 2022  -0.74       -0.74      -0.65     Beat    12.3​
 Jun. 30 2022  -0.82       -0.81      -0.82     Missed  -1
 ​​Mar.        -0.73       -0.75      -0.78     Missed  -4
 31 2022                                                
 Dec. 31 2021  -0.76       -0.76      -0.68     Beat    10.4​
 Sep. 30 2021  -0.68       -0.69      -0.75     Missed  -8.7
 Jun. 30 2021  -0.67       -0.67      -0.64     Beat    4.4
 This summary was machine generated August 4 at 14:01 GMT.  All
figures in US dollars  unless otherwise stated